Abstract
Food bioactives represent diet based molecules that perform physiological roles related to disease prevention and/or treatment. As such considerable overlap exists between food bioactives and drugs, the purpose of this overview is to present the case for comparing and contrasting foods versus drugs in several models of health and disease, some of which are presented in further detail in subsequent chapters of this miniseries. The present review concludes that in some instances distinction is difficult between metabolic processes influenced by foods versus drugs and that the two types of compounds exerts overlapping or identical actions in prevention and treatment of disease. In summary, there appears to be evidence of a role for functional foods in disease treatment, thus we need to look at a paradigm shift to decrease the dependency on drugs and increase the use of food based materials for therapeutic use. Over the longer term, functional foods and nutraceuticals must find ways to compete with pharmaceuticals on an even playing field.
Keywords: Bioprocesses, drugs, food bioactives, metabolic actions, synergism
Current Pediatric Reviews
Title:Food Bioactives versus Drugs – Introduction
Volume: 8 Issue: 3
Author(s): Emanuel Lebenthal and Peter J.H. Jones
Affiliation:
Keywords: Bioprocesses, drugs, food bioactives, metabolic actions, synergism
Abstract: Food bioactives represent diet based molecules that perform physiological roles related to disease prevention and/or treatment. As such considerable overlap exists between food bioactives and drugs, the purpose of this overview is to present the case for comparing and contrasting foods versus drugs in several models of health and disease, some of which are presented in further detail in subsequent chapters of this miniseries. The present review concludes that in some instances distinction is difficult between metabolic processes influenced by foods versus drugs and that the two types of compounds exerts overlapping or identical actions in prevention and treatment of disease. In summary, there appears to be evidence of a role for functional foods in disease treatment, thus we need to look at a paradigm shift to decrease the dependency on drugs and increase the use of food based materials for therapeutic use. Over the longer term, functional foods and nutraceuticals must find ways to compete with pharmaceuticals on an even playing field.
Export Options
About this article
Cite this article as:
Lebenthal Emanuel and J.H. Jones Peter, Food Bioactives versus Drugs – Introduction, Current Pediatric Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339612802139451
DOI https://dx.doi.org/10.2174/157339612802139451 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transdermal Delivery of Diltiazem Hydrochloride from Poloxamer-HPMC Gel: in vitro, ex vivo, and in vivo Studies
Drug Delivery Letters The Lung Disease of Rheumatoid Arthritis
Current Respiratory Medicine Reviews Vascular Calcifications in Chronic Kidney Disease: Are There New Treatments?
Current Vascular Pharmacology Inflammation, Adiponectin, Obesity and Cardiovascular Risk
Current Medicinal Chemistry Calcium Ions in Inherited Cardiomyopathies
Medicinal Chemistry Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
Current Alzheimer Research Nuclear Membranes GPCRs: Implication in Cardiovascular Health and Diseases
Current Vascular Pharmacology Patent Selections
Recent Patents on Cardiovascular Drug Discovery Comparison of Valvulopathy Risk with Lorcaserin and Phenterminetopiramate for Weight Loss
Current Drug Therapy Telmisartan Inhibits Advanced Glycation End Products (AGEs)-Elicited Endothelial Cell Injury by Suppressing AGE Receptor (RAGE) Expression Via Peroxisome Proliferator-Activated Receptor-γ Activation
Protein & Peptide Letters Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research A DNA Repair Pathway Polymorphism (rs25487) and Angiographically Proven Coronary Artery Patients in a Population of Southern Iran
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects of Thiazolidinediones Beyond Glycaemic Control
Current Pharmaceutical Design Consequences of Type 1 and 2 Diabetes Mellitus on the Cardiovascular Regulation During Exercise: A Brief Review
Current Diabetes Reviews Association Between C1236T (rs1128503) Variant in ABCB1 Gene and Breast Cancer Recurrence
Clinical Cancer Drugs Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Recent Patents on CNS Drug Discovery (Discontinued) Vitexin with its Derivatives is Responsible for the Cholinomimetic Properties of <i>Penianthus longifolius</i> Extract which Stimulates Muscarinic Receptors
The Natural Products Journal IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases
Current Medicinal Chemistry Graphical Abstracts:
Current Nutrition & Food Science